A 51-year-old woman with dyspnea. 2013

Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
Department of Medicine, Mayo Clinic, Rochester, MN, USA. liang.jackson@mayo.edu

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011152 Popliteal Vein The vein formed by the union of the anterior and posterior tibial veins; it courses through the popliteal space and becomes the femoral vein. Popliteal Veins,Vein, Popliteal,Veins, Popliteal
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D004417 Dyspnea Difficult or labored breathing. Orthopnea,Platypnea,Recumbent Dyspnea,Rest Dyspnea,Trepopnea,Breathlessness,Shortness of Breath,Breath Shortness,Dyspnea, Recumbent,Dyspnea, Rest,Dyspneas, Rest
D005260 Female Females
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075202 Contraindications A condition or factor associated with a recipient that makes the use of a drug, procedure, or physical agent improper or inadvisable. Contraindications may be absolute (life threatening) or relative (higher risk of complications in which benefits may outweigh risks). Contraindications, Physical Agent,Medical Contraindications,Agent Contraindication, Physical,Agent Contraindications, Physical,Contraindication,Contraindication, Medical,Contraindication, Physical Agent,Contraindications, Medical,Medical Contraindication,Physical Agent Contraindication,Physical Agent Contraindications
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
April 2021, Chest,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
November 2023, Chest,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
August 2017, Clinical practice and cases in emergency medicine,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
April 2008, Brain pathology (Zurich, Switzerland),
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
May 2024, Mayo Clinic proceedings,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
February 2022, JAMA cardiology,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
January 2021, Anatolian journal of cardiology,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
September 2009, Chest,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
July 2022, Chest,
Jackson Jeikai Liang, and Andrew D Goldberg, and Bekele Afessa
August 2008, Chest,
Copied contents to your clipboard!